The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose –response of randomized clinical trials
ConclusionsBreast cancer patients receiving metformin as treatment for diabetes showed significant reduction in levels of insulin, fasting glucose, CRP, HOMA, leptin, BMI, and Ki-67.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cholesterol | Clinical Trials | Databases & Libraries | Diabetes | Endocrinology | Fortamet | Insulin | Metformin | Study